We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

90 hedge funds and large institutions have $20.4M invested in Zomedica Corp. in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

7% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 15

1% less funds holding

Funds holding: 91 → 90 (-1)

13% less capital invested

Capital invested by funds: $23.5M → $20.4M (-$3.07M)

Holders
90
Holders Change
-1
Holders Change %
-1.1%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
16
Reduced
15
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ProShare Advisors
ProShare Advisors
Maryland
+$522K
2
Jane Street
Jane Street
New York
+$166K
3
Charles Schwab
Charles Schwab
California
+$101K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$94.7K
5
BCI
Brinker Capital Investments
Pennsylvania
+$87.6K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$258K
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$52.3K
3
Morgan Stanley
Morgan Stanley
New York
-$47.9K
4
MCC
Money Concepts Capital
Florida
-$24.8K
5
Renaissance Technologies
Renaissance Technologies
New York
-$21K
Name Holding Trade Value Shares
Change 		Change in
Stake
IWA
51
IVC Wealth Advisors
Pennsylvania
$4.23K +$4.9K +20,000 New
M&T Bank
52
M&T Bank
New York
$4.17K – – –
Thrivent Financial for Lutherans
53
Thrivent Financial for Lutherans
Minnesota
$4K – – –
Cetera Investment Advisers
54
Cetera Investment Advisers
Illinois
$3.94K – – –
Goldman Sachs
55
Goldman Sachs
New York
$3.94K +$4.56K +18,596 New
PFS
56
Prospera Financial Services
Texas
$3.65K – – –
ODG
57
O'Dell Group
Ohio
$3.6K – – –
Fidelity Investments
58
Fidelity Investments
Massachusetts
$3.47K -$52.3K -213,215 -93%
PVH
59
Psagot Value Holdings
Israel
$3K +$2.96K +12,089 New
SWA
60
Strategies Wealth Advisors
Michigan
$2.65K – – –
CIA
61
Cape Investment Advisory
Georgia
$2.54K +$2.94K +12,000 New
IWM
62
IHT Wealth Management
Illinois
$2.46K – – –
AWM
63
AE Wealth Management
Kansas
$2.43K +$2.81K +11,458 New
CSPIA
64
Cary Street Partners Investment Advisory
Virginia
$2.18K – – –
Prudential Financial
65
Prudential Financial
New Jersey
$2.16K – – –
BRWA
66
B. Riley Wealth Advisors
Florida
$2.12K – – –
GWM
67
Grand Wealth Management
Michigan
$2.12K – – –
IAIM
68
International Assets Investment Management
Florida
$2.12K – – –
RCA
69
Ranch Capital Advisors
Florida
$2.12K – – –
Citigroup
70
Citigroup
New York
$2.11K – – –
HFS
71
Hantz Financial Services
Michigan
$2K – – –
TFS
72
Thoroughbred Financial Services
Tennessee
$2K +$2.45K +10,000 New
AWM
73
Accel Wealth Management
Iowa
$1.66K – – –
SWM
74
Spire Wealth Management
Virginia
$1.06K -$13 -54 -1%
CFFP
75
Center for Financial Planning
Michigan
$1.06K – – –
1 2
3
4

ZOM Hedge Fund Activity: Q1 2023 in Review

90 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2023, worth a combined $20.4M — down 13% from $23.5M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ZOM positions and 11 closed out — a net gain of 3 holders — while 16 added to existing stakes and 15 trimmed.

The largest buyer was ProShare Advisors, opening a new position worth an estimated $522K. The largest seller was BlackRock, cutting an estimated $258K.

  • 90 institutional investors held Zomedica Corp. (ZOM) as of Q1 2023, down from 91 in Q4 2022.
  • Funds reported $20.4M of Zomedica Corp. stock for Q1 2023, down 13% quarter-over-quarter.
  • 14 funds opened new Zomedica Corp. positions in Q1 2023 and 11 closed out, a net change of +3 holders.
  • The largest Zomedica Corp. buyer in Q1 2023 was ProShare Advisors, an estimated $522K added.
  • The largest Zomedica Corp. seller in Q1 2023 was BlackRock, an estimated $258K sold.

Based on aggregated 13F filings for Q1 2023.